QbD Group
    Upcoming Webinar

    EU GMP Annex 1 Implementation

    From Regulatory Expectations to Practical Remediation

    This webinar translates the revised EU GMP Annex 1 requirements into structured, practical actions across sterile manufacturing environments. Learn how to assess implementation challenges, prioritize remediation efforts and strengthen sustainable compliance.

    Thursday, April 30, 2026
    4 PM CEST / 2 PM GMT
    Qualification & Validation · Quality Assurance
    English

    About this webinar

    The revised EU GMP Annex 1 represents one of the most significant regulatory updates for sterile manufacturing in recent years. Beyond interpretation, authorities now expect demonstrable, fact & risk-based and sustainable implementation across facilities, utilities, quality systems and contamination control strategies. "Risk"-based arguments for not being compliant are not accepted anymore.

    This webinar provides a structured approach to Annex 1 readiness and remediation. Our experts will explore the historical evolution of Annex 1, analyze the practical challenges manufacturers face, and focus on critical remediation areas frequently linked to inspection findings.

    Drawing on regulatory trends and insights from FDA warning letters, the session connects regulatory expectations with real-world implementation strategies to support decision-making at site level.

    What you'll learn

    • How Annex 1 evolved and why its implementation requires a cross-functional, risk-based approach
    • How to identify and prioritize remediation areas based on inspection trends, time for implementation and operational risk
    • What regulators expect in the most critical implementation areas under Annex 1
    • What FDA warning letters reveal about Annex 1 readiness and recurring non-conformities
    • How to structure a practical remediation roadmap aligned with sustainable compliance

    Learn from the best

    Speakers

    This session brings together decades of hands-on experience in sterile manufacturing, GMP compliance, and contamination control strategy. Our speakers combine deep technical expertise with regulatory insight gained from global leadership roles at organizations including Alcon, Novartis, and Sandoz — offering practical guidance you can apply directly to your Annex 1 remediation journey.

    Jo Doucet

    Jo Doucet

    Global Head Qualification & Validation, QbD Group

    Jo Doucet is an expert in qualification and validation with over 20 years of experience in the pharmaceutical industry. He leads the Qualification/Validation division at QbD Group, supporting teams and clients in GxP compliance projects across manufacturing, IT, QC, and medical devices.

    Geert Vandenbossche, PhD

    Geert Vandenbossche, PhD

    Founder & Owner, C&E Solutions

    Geert brings 30 years of senior leadership experience from Alcon/Novartis across both global and site roles. As Global Head of Engineering and MS&T, he successfully integrated the Advanced Accelerator Applications start-up into the Novartis Radioligand Therapy unit. Earlier, Geert served as Global Head of Quality for all Sandoz Sterile and for Novartis Biologic sites, leading Global Quality Strategic Initiatives with a key focus on Annex-1 aseptic processing.

    Starts in

    04Days
    16Hours
    39Min
    26Sec

    Register here

    Is this for you?

    Who should attend?

    This webinar is ideal for professionals working in sterile manufacturing and GMP compliance.

    Site Heads and Plant Managers

    Heads of Manufacturing and Operations Directors

    Quality Directors and QA Managers

    Engineering, Validation and Technical Operations Leads

    Cross-functional teams responsible for CCS, remediation planning and execution

    Keep watching

    More webinars

    AI in Life Sciences: Session 2, Your Questions Answered Upcoming Webinar

    AI in Life Sciences: Session 2, Your Questions Answered

    Software Solutions & ServicesMay 13, 2026

    Adopting AI in life sciences holds enormous potential, but navigating GxP requirements adds real complexity. In this joint session, QbD Group and delaware walk you through how to deploy AI that is trustworthy, validated, and inspection-ready, covering data governance, explainability, and lifecycle management. Building on the first session, this edition dedicates more time to answering your questions, addressing the topics raised by the audience in Session 1, and opening the floor for live debate and discussion.

    Register now
    Manufacturing Quality & Compliance

    Need Manufacturing Quality & Compliance support?

    QbD Group helps pharma and biotech manufacturers strengthen manufacturing performance through integrated quality, compliance, and operational expertise, keeping sites efficient, compliant, and inspection-ready.